๐ฐ Early Charm News
Early Charm News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Early Charm. Real-time updates on events, politics, business and more.
December 5, 2023
ComputChem Launches State-of-the-Art Approach to Predicting pKa Values ...
August 17, 2023
The investment and tech commercialization firm's move is backed by state and industry. Here's why CEO Ken Malone deems that support especially important for the manufacturing industry.
August 8, 2023
A coalition of Baltimore's corporations and institutions is ready to merge AI and biotech in pursuit of an ambitious target: federal designation from the new US Economic Development Administration program.
September 12, 2022
Malone is the Managing Director of Early Charm and the CEO of SilcsBio, one of the 37 portfolio companies that operate under Early Charmโs novel Venture Studio Mode
September 6, 2022
Read about how Fulton Bank has supported life science companies such as CarrTech, Early Charm Ventures, The Launchport, Ellume, and more.
December 13, 2021
View the winners of the 2021 BioBuzz Awards, a celebration of the exciting work being done by the BioHealth Capital Region community.
October 20, 2021
WYNNEWOOD, PA / ACCESSWIRE / October 20, 2021 / For a hospital system to be a hub of medical invention runs counter to preconceived notions of its role as a healthcare provider. Then again, the person
May 25, 2021
L2C Partners, a consulting firm that offers outsourced technology transfer and commercialization services. Keeley, a biomedical engineer and veteran technology commercialization expert, will lead Lankenau Venturesโ core objective to license inventions from LIMR that focus on the operating room, the hospital patient room and other healthcare venues. In commercializing those inventions, the qualities of safety, quality and efficacy will be matched with market demand to determine priorities for ...
May 19, 2021
(0) WYNNEWOOD, PA / ACCESSWIRE / May 19, 2021 / Lankenau Ventures is a new business established to accelerate development and commercialization of medical inventions conceived by frontline healthcare workers. It is an initiative comprising a leading medical research institute and commercialization and entrepreneurship experts. The joint venture includes the Lankenau Institute for Medical Research (LIMR; the research division of Main Line Health) and L2C Partners, both in Philadelphia and Early ...
May 19, 2021
WYNNEWOOD, PA / ACCESSWIRE / May 19, 2021 / Lankenau Ventures is a new business established to accelerate development and commercialization of medical inventions conceived by frontline healthcare workers. It is an initiative comprising a leading medical research institute and commercialization and entrepreneurship experts.